A Cost-Effectiveness Analysis of Screening for Hepatitis B Surface Antigen in India

Abstract

Get full access to this article

View all access options for this article.

References

Pal SR , Chitkara NL , Choudhary S. , Dutta DV , Deadhar SD , Chhuttani PN : Hepatitis B virus infection in northern India. Bull WHO 51: 13-17, 1974

John JJ , Carman RH , Hill PG : Hepatitis B antigen and viral hepatitis type B in India. Bull WHO 51: 617-620, 1974

Gerety RJ , Hoofnagle JH , Mitchell FD , Barber LF , Meyer HM : Evaluation of hepatitis B antigen testing in federally licensed blood banks in the United States. Am J Clin Pathol 63: 573-580, 1975

Barbara JA , Howell DR , Cleghorn DE , Cameron CH , Briggs M. , Dane S. : A comparison of different methods of screening blood donations for HBsAg. Vox Sang 32: 4-9, 1977

Abbott Laboratories : Antibody to hepatitis B surface antigen 125I (human) Ausria II-125. North Chicago: Abbott Laboratories, 1976, pp 17-20

Seeff LB , Wright EC , Zimmerman HJ , Finkelstein JD , Garcia-Pont P. , Greenlee HB , Dietz AA , et al.: VA cooperative study of post-transfusion hepatitis, 1969-1974. Incidence and characteristics of hepatitis and responsible risk factors. Am J Med Sci 270: 355-362, 1975

Pattanayak S. Arora DD , Singha P. , Raghavan Ngs : Epidemiological studies on viral hepatitis in Delhi. New Delhi, India: Indian Council of Medical Research (Technical Report No. 24), 1973, pp 54-72

Madanagopalan N. : High mortality factors in viral hepatitis. New Delhi, India: Indian Council of Medical Research (Technical Report No. 24), 1973, pp 101-111

Weinstein MC , Stason WB : Foundation of cost-effective analysis for health and medical practice. N Engl J Med 296: 716-721, 1977